Cite
HARVARD Citation
Rahal, S. et al. (2015). Immunohistochemical subtypes predict the clinical outcome in high-risk node-negative breast cancer patients treated with adjuvant FEC regimen: results of a single-center retrospective study. BMC cancer. 15 (1), pp. 1-11. [Online].